SunTrust Robinson Humphrey Downgrades St. Jude Medical (STJ) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq futures outperform after Nvidia puts AI fears to rest
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil gains as traders weigh prospects of easing Middle East supply disruptions
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
UBS Downgrades St. Jude Medical (STJ) to Neutral
May 12, 2016 7:10 AM EDT(Updated)
UBS downgraded St. Jude Medical (NYSE: STJ) from Buy to Neutral.
Analyst Matt Miksic said, "We expect the stock to trade primarily on the deal price and less on the fundamentals going forward. The transaction is expected to close in 4Q16,... More
